Announce Date | 02/13/2025 |
EPS Normalized Actual | $2.32 (Beat by $0.12) |
EPS GAAP Actual | $2.32 (Beat by $0.12) |
Revenue Actual | $10.404B |
Revenue Surprise | Beat by $10404M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 10.8 | 11.83 | 10.20735 | 11.35706 | 1 |
Dec 2028 | 9.2 | 13.88 | 8.49733 | 9.64358 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.59 | 1.59 | 10.404B | 100% | 10404M |
FQ3 2024 (Sep 2024) | 0.73 | 0.73 | 9.036B | 12.93% | 9036M |
FQ2 2024 (Jun 2024) | 0.42 | 0.42 | 8.391B | 8% | 8391M |
FQ1 2024 (Mar 2024) | 0.41 | 0.41 | 7.935B | -3.27% | 7935M |
FQ3 2023 (Sep 2023) | 0.61 | 0.61 | 7.86805B | 4.3% | 7868.05M |
FQ2 2001 (Jun 2001) | 63801 | 63801 | 0B | NAN% | 0M |
FQ2 2023 (Jun 2023) | 0.65 | 0.65 | 7.71986B | -0.67% | 7719.86M |
FQ1 2023 (Feb 2023) | 0.25 | 0.25 | 8.19449B | 100% | 8194.49M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.7989 | -- | 1.72712 | 1.87737 | 1 |
FQ3 2027 (Jul 2027) | 1.5867 | -- | 1.52339 | 1.65592 | 1 |
FQ2 2027 (Jun 2027) | 1.58671 | -- | 1.50942 | 1.66451 | 2 |
FQ1 2027 (Mar 2027) | 1.23205 | -- | 1.17204 | 1.29246 | 2 |
FQ4 2026 (Oct 2026) | 1.70555 | -- | 1.63749 | 1.77995 | 1 |
FQ3 2026 (Jul 2026) | 1.38345 | -- | 1.32825 | 1.4438 | 1 |
FQ2 2026 (Jun 2026) | 1.50347 | -- | 1.43023 | 1.57719 | 3 |
FQ1 2026 (Mar 2026) | 1.31146 | -- | 1.24758 | 1.37577 | 3 |
FQ4 2025 (Oct 2025) | 1.39233 | -14.2 | 1.33677 | 1.45307 | 2 |
FQ3 2025 (Sep 2025) | 1.40883 | 48.18 | 1.33889 | 1.46226 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 6.44B | -- | 6.24B | 6.66B | 2 |
FQ3 2027 (Jul 2027) | 6.06B | -- | 5.87B | 6.26B | 2 |
FQ2 2027 (Jun 2027) | 6.06B | -- | 5.83B | 6.29B | 2 |
FQ1 2027 (Mar 2027) | 5.68B | -- | 5.46B | 5.89B | 2 |
FQ4 2026 (Oct 2026) | 8.51B | -- | 8.25B | 8.8B | 2 |
FQ3 2026 (Jul 2026) | 8.12B | -- | 7.87B | 8.4B | 2 |
FQ2 2026 (Jun 2026) | 8.09B | -- | 7.79B | 8.39B | 2 |
FQ1 2026 (Mar 2026) | 7.75B | -- | 7.46B | 8.04B | 2 |
FQ4 2025 (Oct 2025) | 8.15B | -27.6 | 7.9B | 8.43B | 1 |
FQ3 2025 (Sep 2025) | 9.39B | 3.8 | 9.03B | 9.67B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.59 | 1.59 | 100% | |
FQ3 2024 (Sep 2024) | 0.73 | 0.73 | 100% | |
FQ2 2024 (Jun 2024) | 0.42 | 0.42 | 100% | |
FQ1 2024 (Mar 2024) | 0.41 | 0.41 | 100% | |
FQ3 2023 (Sep 2023) | 0.61 | 0.61 | 100% | |
FQ2 2001 (Jun 2001) | 63801 | 63801 | 100% | |
FQ2 2023 (Jun 2023) | 0.65 | 0.65 | 100% | |
FQ1 2023 (Feb 2023) | 0.25 | 0.25 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $10.4B | $10404M | 100% |
FQ3 2024 (Sep 2024) | $0B | $9.04B | $9036M | 100% |
FQ2 2024 (Jun 2024) | $0B | $8.39B | $8391M | 100% |
FQ1 2024 (Mar 2024) | $0B | $7.94B | $7935M | 100% |
FQ3 2023 (Sep 2023) | $0B | $7.87B | $7868.05M | 100% |
FQ2 2001 (Jun 2001) | $0B | $0B | $0M | NAN% |
FQ2 2023 (Jun 2023) | $0B | $7.72B | $7719.86M | 100% |
FQ1 2023 (Feb 2023) | $0B | $8.19B | $8194.49M | 100% |